- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
HBA and Healthcare Companies Partner in Gender Parity Collaborative
The Healthcare Businesswomen’s Association (HBA) announced that 12 healthcare and life science companies have started a partnership to advance gender parity progress in the industry. The founding member companies serve as role models with all 12 organizations supporting internal women’s leadership networks and more than half recognized by national business media outlets for progressive diversity and inclusion programs, along with representing a work force of more than 750,000 employees collectively globally.
While similar corporate partnerships exist, the HBA’s Collaborative is different in that all member companies are in the healthcare and life science business. The twelve founding member companies are Advanced Clinical, Bristol-Myers Squibb, Celgene, Eli Lilly and Company, GlaxoSmithKline, Medidata Solutions, Novartis, Pfizer, Quest Diagnostics, Genentech, a member of the Roche group, and Sanofi.
The State of Mining Data Insights in the Life Sciences Industry – 2024
April 30th 2024A Frost & Sullivan industry-wide survey reveals which insights most pharmaceutical companies have mastered and which are still painful or impossible to extract and details the complexity of the process, the confidence companies have in their findings, and more. Hear Web Sun, President and Co-founder of Komodo Health, share what's driving these challenges and how you can overcome them.
